NCT06310330View on ClinicalTrials.gov

TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

March 8, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Breast Neoplasm Malignant Primary
Interventions
DIAGNOSTIC_TEST

Comprehensive echocardiographic follow-up

Comprehensive echocardiographic follow-up for identification of CRTCD in breast cancer patients

DIAGNOSTIC_TEST

Simplified echocardiographic follow-up

Simplified echocardiographic follow-up for identification of CRTCD in breast cancer patients

Trial Locations (1)

7491

RECRUITING

St. Olavs hospital, Trondheim

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

lead

Norwegian University of Science and Technology

OTHER